Action Potential Venture Capital
Overview
Action Potential Venture Capital (APVC) is a venture capital firm dedicated to advancing bioelectronic medicines and their enabling technologies. Founded in 2013 by GlaxoSmithKline (GSK), APVC invests globally in companies that are pioneering the development of bioelectronic medicines, a therapeutic field that leverages advances in hardware, computing, and material science to regulate neural or cellular activity for the treatment of chronic diseases. APVC takes an active role on the boards of start-ups, providing strategic guidance and support to accelerate the commercialization of innovative medical technologies. APVC's investment strategy focuses on early to late-stage companies across various therapeutic areas, including oncology, neurology, cardiology, endocrinology, immunology, rheumatology, pulmonology, gastroenterology, orthopedics, ophthalmology, dermatology, urology, and otolaryngology. The firm seeks to invest in companies developing bioelectronic medicines and enabling technologies that can effectively treat a range of chronic diseases. APVC's portfolio includes companies such as SetPoint Medical, Alpheus Medical, MicroTransponder, Saluda Medical, and Cala Health. APVC is committed to fostering an inclusive and diverse workspace and extends this commitment to the companies it invests in. The firm believes in the fundamental advantage of an inclusive and diverse workspace and is dedicated to creating a more equitable healthcare investor and entrepreneurial community. APVC's team comprises professionals with expertise in venture capital, bioelectronics, and medical technology, working collaboratively to identify and support innovative companies that have the potential to transform healthcare through bioelectronic medicines.
Investment Focus
- Companies developing bioelectronic medicines and enabling technologies
- Innovative medical technologies addressing chronic diseases
- Start-ups with potential for commercialization and scalability
- Companies with diverse and inclusive teams
- Entrepreneurial teams committed to advancing healthcare through bioelectronics
Portfolio Companies
Reach Action Potential Venture Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Action Potential Venture Capital
What sectors does Action Potential Venture Capital invest in?
Action Potential Venture Capital invests in Healthcare, Digital Health, Pharmaceuticals, Medical Devices, Biotechnology and Oncology, and is based in Palo Alto, California, United States. Action Potential Venture Capital is listed as a venture capital in the ConnectSafely investor database.
What stage does Action Potential Venture Capital invest at?
Action Potential Venture Capital backs companies at Early Stage, Series A, Series B, Growth, Late Stage and Pre-IPO, writing cheques of 5M - 20M.
Which regions does Action Potential Venture Capital invest in?
Action Potential Venture Capital invests across United States, United Kingdom, Germany, France, Italy and Denmark.
Who are the partners at Action Potential Venture Capital?
Team members listed for Action Potential Venture Capital include Juan-Pablo Mas (Managing Director) and Suraj Mudichintala (Principal).
What companies has Action Potential Venture Capital invested in?
Action Potential Venture Capital's portfolio includes Saluda Medical, Alpheus Medical, SetPoint Medical, Cala Health and MicroTransponder.
How do I contact Action Potential Venture Capital?
Action Potential Venture Capital's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database